ALZA Pharmaceuticals

ALZA Corporation is the leading provider of drug delivery solutions with the world’s broadest array of technology platforms, including oral, transdermal, implantable and liposomal technologies. ALZA partners with pharmaceutical and biotechnology companies to develop and manufacture pharmaceutical products that enhance healthcare for millions of patients worldwide. ALZA provides value to our partners in all phases of product development, from initial concept, through manufacturing and commercialization. Many of our collaborations begin in the early phases of product development, using our pharmacologic discovery process to identify optimal delivery profiles. This process pushes the boundaries of drug delivery, and yields highly attractive options for partner companies to commercialize novel therapies. Through a merger completed on June 22, 2001, ALZA Corporation became a wholly owned subsidiary of Johnson & Johnson, the world’s most comprehensive and broadly based manufacturer of heal


Harold Fethe (VP HR)

Jerry Jackson (Board Member)

Michele Miller (Director of Marketing)

Carol Gamble (General Counsel)

Ernest Mario (President/CEO)

View more details about all 6 people at ALZA Pharmaceuticals


Taiwan Liposome Company: Taiwan Liposome Company (TLC) is a biopharmaceutical company engaging in research, development and commercialization of proprietary… See Company Profile »
TransPharma Medical: Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and… See Company Profile »
Chiasma: Chiasma creates proprietary oral drug products that lengthen the Life Cycle of compounds (increase market size… See Company Profile »
Isis Biopolymer: Isis Biopolymer, Inc. ("Isis") is an early stage, Rhode Island-based medical device company. Isis has developed… See Company Profile »

View more details about this company's competitors